HSCT cures interleukin-10 (IL10) signalling defects causing IBD.4 In contrast, it does not improve intestinal inflammation in TTC7A deficiency,16 a disease manifesting with IBD, intestinal atresia and immunodeficiency. This evidence concerns the gene IL10 and inflammatory bowel disease.